Review



primary antibodies cited2  (ABclonal Biotechnology)


Bioz Verified Symbol ABclonal Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    ABclonal Biotechnology primary antibodies cited2
    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; <t>CITED2,</t> CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Primary Antibodies Cited2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies cited2/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies cited2 - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke"

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    Journal: Frontiers in Neurology

    doi: 10.3389/fneur.2022.1000992

    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Figure Legend Snippet: Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.

    Techniques Used: Diffusion-based Assay, Western Blot, Modification

    Patient selection. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot.
    Figure Legend Snippet: Patient selection. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot.

    Techniques Used: Selection, Diffusion-based Assay, Western Blot

    Protein expression of CITED2 and VEGF.
    Figure Legend Snippet: Protein expression of CITED2 and VEGF.

    Techniques Used: Expressing

    Clinical data of the included patients.
    Figure Legend Snippet: Clinical data of the included patients.

    Techniques Used: Significance Assay

    Univariate logistic regression analysis of collateral circulation-related factors in AIS.
    Figure Legend Snippet: Univariate logistic regression analysis of collateral circulation-related factors in AIS.

    Techniques Used:

    Multivariate logistic regression analysis of collateral circulation-related factors in AIS.
    Figure Legend Snippet: Multivariate logistic regression analysis of collateral circulation-related factors in AIS.

    Techniques Used:

    ROC curve analysis of the VEGF/CITED2 in the collateral circulation of AIS.
    Figure Legend Snippet: ROC curve analysis of the VEGF/CITED2 in the collateral circulation of AIS.

    Techniques Used:

    ROC analysis of the poor collateral circulation in AIS.
    Figure Legend Snippet: ROC analysis of the poor collateral circulation in AIS.

    Techniques Used:



    Similar Products

    90
    Abmart Inc primary antibodies against cited2
    Primary Antibodies Against Cited2, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cited2/product/Abmart Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against cited2 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    93
    Proteintech primary antibodies against cited2
    Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 <t>(Cited2)</t> expression was down-regulated in hypoxia-induced pulmonary hypertension (HPH) rat models
    Primary Antibodies Against Cited2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cited2/product/Proteintech
    Average 93 stars, based on 1 article reviews
    primary antibodies against cited2 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology primary antibodies cited2
    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; <t>CITED2,</t> CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Primary Antibodies Cited2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies cited2/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies cited2 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary antibody against cited2 sc25375
    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; <t>CITED2,</t> CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Primary Antibody Against Cited2 Sc25375, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against cited2 sc25375/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against cited2 sc25375 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology primary antibody against cited2
    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; <t>CITED2,</t> CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Primary Antibody Against Cited2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against cited2/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    primary antibody against cited2 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    90
    Novus Biologicals primary antibody to cited2
    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; <t>CITED2,</t> CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.
    Primary Antibody To Cited2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody to cited2/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    primary antibody to cited2 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in hypoxia-induced pulmonary hypertension (HPH) rat models

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in hypoxia-induced pulmonary hypertension (HPH) rat models

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Expressing

    Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in pulmonary artery smooth muscle cells (PASMCs) in hypoxia

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in pulmonary artery smooth muscle cells (PASMCs) in hypoxia

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Expressing

    Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) overexpression on pulmonary artery smooth muscle cells (PASMCs)

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) overexpression on pulmonary artery smooth muscle cells (PASMCs)

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Over Expression

    Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) knockdown on pulmonary artery smooth muscle cells (PASMCs)

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) knockdown on pulmonary artery smooth muscle cells (PASMCs)

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Knockdown

    Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) reversed Transforming growth factor-beta1 (TGF-β1)-induced proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) reversed Transforming growth factor-beta1 (TGF-β1)-induced proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Migration

    Peroxisome proliferatoractivated receptor gamma (PPARγ) cooperates with Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) to inhibit the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)

    Journal: Iranian Journal of Basic Medical Sciences

    Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway

    doi: 10.22038/IJBMS.2023.74455.16178

    Figure Lengend Snippet: Peroxisome proliferatoractivated receptor gamma (PPARγ) cooperates with Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) to inhibit the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)

    Article Snippet: A protein-free quick blocking solution (Boster, AR0041) was used to block the membrane at room temperature for 1 hr, and then primary antibodies against Cited2 (1:500, Affinity), anti-PPARγ (1:2000, Proteintech), and anti-β-actin (1:3000, Affinity) were used to incubate the membranes overnight at 4 ° C. On the next day, HRP-labeled secondary antibody (1:5000, Affinity) was used to incubate the membranes at room temperature for 1 hr, and the chemiluminescence method was used for color development.

    Techniques: Migration

    Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Schedule of enrollment and assessments. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot; NIHSS, National Institute of Health Stroke Scale; MBI, Modified Barthel Index; mRS, Modified Rankin Scale.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques: Diffusion-based Assay, Western Blot, Modification

    Patient selection. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Patient selection. DWI-ASPECTS, diffusion weight image–Alberta Stroke Program Early CT Score; CITED2, CBP/P300-interacting transactivator with Glu/Asp-rich C-terminal domain 2; VEGF, vascular endothelial growth factor; WB, Western blot.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques: Selection, Diffusion-based Assay, Western Blot

    Protein expression of CITED2 and VEGF.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Protein expression of CITED2 and VEGF.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques: Expressing

    Clinical data of the included patients.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Clinical data of the included patients.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques: Significance Assay

    Univariate logistic regression analysis of collateral circulation-related factors in AIS.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Univariate logistic regression analysis of collateral circulation-related factors in AIS.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques:

    Multivariate logistic regression analysis of collateral circulation-related factors in AIS.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: Multivariate logistic regression analysis of collateral circulation-related factors in AIS.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques:

    ROC curve analysis of the VEGF/CITED2 in the collateral circulation of AIS.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: ROC curve analysis of the VEGF/CITED2 in the collateral circulation of AIS.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques:

    ROC analysis of the poor collateral circulation in AIS.

    Journal: Frontiers in Neurology

    Article Title: VEGF to CITED2 ratio predicts the collateral circulation of acute ischemic stroke

    doi: 10.3389/fneur.2022.1000992

    Figure Lengend Snippet: ROC analysis of the poor collateral circulation in AIS.

    Article Snippet: The membrane was probed with diluted primary antibodies CITED2 (Abclonal, 1:1,000), VEGF (Bioss, 1:1,000), and β-actin (Bioworld, 1:10,000) overnight at 4°C.

    Techniques: